MORGAN DEMPSEY CAPITAL MANAGEMENT LLC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 86 filers reported holding UTAH MED PRODS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$77,056
-7.4%
896
+0.3%
0.02%0.0%
Q2 2023$83,228
-85.1%
893
-84.8%
0.02%
-84.1%
Q1 2023$558,480
+437.0%
5,893
+389.9%
0.15%
+357.6%
Q1 2021$104,000
+65.1%
1,203
+60.6%
0.03%
+26.9%
Q4 2020$63,000
-1.6%
749
-7.2%
0.03%
+4.0%
Q3 2020$64,000
-22.0%
807
-12.6%
0.02%
-26.5%
Q2 2020$82,000
-15.5%
923
-10.6%
0.03%
-27.7%
Q1 2020$97,000
-53.4%
1,033
-46.4%
0.05%
-43.4%
Q4 2019$208,000
-78.3%
1,926
-80.8%
0.08%
-76.4%
Q3 2019$959,000
-7.6%
10,009
-7.7%
0.35%
-9.7%
Q2 2019$1,038,000
+3.1%
10,843
-5.0%
0.39%
-2.5%
Q1 2019$1,007,000
+0.7%
11,416
-5.2%
0.40%
-8.7%
Q4 2018$1,000,000
-13.8%
12,040
-2.2%
0.44%
-2.4%
Q3 2018$1,160,000
-15.0%
12,313
-0.6%
0.45%
-16.9%
Q2 2018$1,364,000
-99.9%
12,386
-9.2%
0.54%
+1.9%
Q1 2018$1,348,017,000
-38.7%
13,637
-49.5%
0.53%
-25.0%
Q4 2017$2,198,777,000
+106121.1%
27,012
-4.4%
0.71%
+0.6%
Q3 2017$2,070,000
+4.1%
28,251
+2.9%
0.70%
-2.9%
Q2 2017$1,988,000
+12.7%
27,464
-2.9%
0.72%
+8.7%
Q1 2017$1,764,000
-50.9%
28,290
-42.7%
0.67%
-35.3%
Q4 2016$3,591,000
+21.9%
49,354
+0.2%
1.03%
+3.8%
Q3 2016$2,947,000
-20.4%
49,275
-16.2%
0.99%
-20.8%
Q2 2016$3,702,000
-17.2%
58,767
-17.8%
1.25%
-21.7%
Q1 2016$4,472,000
-25.7%
71,505
-30.4%
1.60%
-30.6%
Q4 2015$6,017,000
-11.2%
102,788
-18.3%
2.31%
-3.8%
Q3 2015$6,779,000
-33.6%
125,833
-26.5%
2.40%
-14.8%
Q2 2015$10,208,000
-5.6%
171,197
-5.3%
2.82%
-0.9%
Q1 2015$10,819,000
-4.5%
180,737
-4.2%
2.84%
-2.8%
Q4 2014$11,333,000
+5.9%
188,732
-14.0%
2.93%
+16.8%
Q3 2014$10,697,000
+0.5%
219,387
+6.0%
2.50%
+6.2%
Q2 2014$10,644,000
-6.8%
206,929
+4.8%
2.36%
-16.6%
Q1 2014$11,421,000
+20.7%
197,495
+19.3%
2.83%
-4.0%
Q4 2013$9,464,000
-18.8%
165,563
-15.6%
2.95%
-27.3%
Q3 2013$11,655,000
+13.2%
196,075
+3.4%
4.05%
+3.4%
Q2 2013$10,299,000189,6633.92%
Other shareholders
UTAH MED PRODS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders